Acupuncture for Peripheral Neuropathy Induced by Paclitaxel in Early Stage Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 30, 2020

Primary Completion Date

November 7, 2023

Study Completion Date

March 26, 2024

Conditions
Peripheral Neuropathy Due to Chemotherapy
Interventions
OTHER

True acupuncture

"The selection of acupuncture points is based on Traditional Chinese Medicine (Wen, 2011) and on previous studies (Jeong,2018; Bao,2018), selected as main points: bilateral baxie, SJ5, bafeng, KID3 and ST36. Modifications or additional secondary points may be indicated according to clinical judgment throughout treatment. The needles will be inserted at a depth of 10 - 15 mm, being gently manipulated to obtain de qi sensation. The needles will be left for 20 - 25 minutes. There will be once a week acupuncture treatment, for 8 consecutive weeks. The acupuncture needles will be sterile, disposable stainless steel needles size 0.20 x 30 mm, of Korean brand Dong Bang, Chungcheongnam-do."

OTHER

Sham acupuncture

"Patients will receive needling at non-acupuncture points with superficial needling without manipulation to obtain de qi, located near the real points in the hands and feet. The needles will also be left for 20 - 25 minutes. There will be once a week acupuncture treatment, for 8 consecutive weeks. There will be once a week acupuncture treatment, for 8 consecutive weeks. The acupuncture needles will be sterile, disposable stainless steel needles size 0.20 x 30 mm, of Korean brand Dong Bang, Chungcheongnam-do."

Trial Locations (1)

03102-006

Instituto Brasileiro de Controle de Cancer (IBCC Oncologia), São Paulo

All Listed Sponsors
lead

Instituto Brasileiro de Controle do Cancer

OTHER

NCT04461977 - Acupuncture for Peripheral Neuropathy Induced by Paclitaxel in Early Stage Breast Cancer | Biotech Hunter | Biotech Hunter